Abstract

The invention consists of alternative compounds to nitisinone, for the treatment of both AKU and HT1.

Research Institution

Università degli Studi di Siena

Numero di pubblicazione

WO2017144583A1

TRL

3

Technologies, Systems, Applications

New drugs development